When it comes to dividend income, there are few industries more sought after than pharmaceutical stocks. More specifically, investors tend to focus on the 10 largest companies by market cap in pharmaceuticals because they’re likely to have established product portfolios, deep drug development pipelines, and significant cash flow that allows them to pay dividends regularly higher than the S&P 500 average of 2%. In fact, of the 10 largest companies by market cap in pharmaceuticals, there isn’t one with a dividend yield lower than 2.2%, and the combined operating cash flow of these 10 companies over the trailing-12-month period equaled — get ready for this — $91.3 billion!
{iframe}http://www.fool.com/investing/general/2015/04/05/10-largest-companies-by-market-cap-in-pharmaceutic.aspx{/iframe}